Xopenex Hfa

  • Asthma/COPD

Xopenex Hfa Generic Name & Formulations

General Description

Levalbuterol (as tartrate) (single-isomer albuterol) 45mcg/inh; metered dose inhaler; CFC-free.

Pharmacological Class

Beta-2 agonist.

How Supplied

Inhaler w. actuator (200 inh)—15g


Generic Availability


Xopenex Hfa Indications



Xopenex Hfa Dosage and Administration

Adults and Children

<4yrs: not established. ≥4yrs: 2 inh every 4–6hrs; or 1 inh every 4hrs may suffice.

Xopenex Hfa Contraindications

Not Applicable

Xopenex Hfa Boxed Warnings

Not Applicable

Xopenex Hfa Warnings/Precautions


Do not exceed recommended dose. Monitor for increased need; if inadequate control, reevaluate and consider adding an antiinflammatory (eg, corticosteroids). Sensitivity to sympathomimetics. Discontinue if paradoxical bronchospasm, cardiovascular effects, or hypersensitivity reactions occur. Cardiovascular disorders (esp. coronary insufficiency, arrhythmias, hypertension). Seizure disorders. Diabetes. Hyperthyroidism. Hypokalemia. Renal impairment; monitor (esp. in elderly). Elderly. Labor & delivery. Pregnancy. Nursing mothers.

Xopenex Hfa Pharmacokinetics

See Literature

Xopenex Hfa Interactions


Avoid within 2 weeks of MAOIs, tricyclic antidepressants. Avoid other short-acting sympathomimetic aerosol bronchodilators, epinephrine. Antagonized by β-blockers. Caution with other drugs that may lower serum potassium (eg, diuretics). Monitor digoxin.

Xopenex Hfa Adverse Reactions

Adverse Reactions

Accidental injury, bronchitis, dizziness, pharyngitis, rhinitis, vomiting, palpitations, chest pain, tachycardia, headache, tremor, nervousness.

Xopenex Hfa Clinical Trials

See Literature

Xopenex Hfa Note

Not Applicable

Xopenex Hfa Patient Counseling

See Literature